CAC
TMO icon

Core Alternative Capital’s Thermo Fisher Scientific TMO Stock Holding History

Core Alternative Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
2,796
-206
-7% -$98.9K 0.42% 61
2026
Q1 		$1.48M Sell
3,002
-142
-5% -$77.1K 0.44% 58
2025
Q4 		$1.82M Buy
3,144
+267
+9% +$151K 0.5% 55
2025
Q3 		$1.4M Sell
2,877
-255
-8% -$119K 0.41% 56
2025
Q2 		$1.27M Sell
3,132
-739
-19% -$309K 0.35% 61
2025
Q1 		$1.93M Sell
3,871
-40
-1% -$21.7K 0.46% 62
2024
Q4 		$2.03M Sell
3,911
-393
-9% -$216K 0.43% 61
2024
Q3 		$2.66M Buy
4,304
+2
+0% +$1.18K 0.51% 60
2024
Q2 		$2.38M Buy
4,302
+8
+0.2% +$4.58K 0.48% 60
2024
Q1 		$2.5M Sell
4,294
-72
-2% -$40.4K 0.45% 60
2023
Q4 		$2.32M Sell
4,366
-187
-4% -$90.5K 0.4% 61
2023
Q3 		$2.3M Buy
4,553
+387
+9% +$206K 0.36% 59
2023
Q2 		$2.17M Buy
4,166
+165
+4% +$89K 0.32% 62
2023
Q1 		$2.31M Sell
4,001
-762
-16% -$429K 0.31% 60
2022
Q4 		$2.62M Sell
4,763
-1
-0% -$530 0.33% 52
2022
Q3 		$2.42M Buy
4,764
+887
+23% +$496K 0.39% 47
2022
Q2 		$2.11M Buy
3,877
+1,363
+54% +$750K 0.5% 44
2022
Q1 		$1.49M Buy
2,514
+1,848
+277% +$1.06M 0.4% 44
2021
Q4 		$444K Buy
666
+619
+1,317% +$386K 0.09% 70
2021
Q3 		$27K Buy
+47
New +$25.8K 0.01% 85

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Core Alternative Capital's TMO Position: Q2 2026 in Review

Core Alternative Capital reduced its Thermo Fisher Scientific (TMO) stake by 6.9% in Q2 2026, selling an estimated $98.9K and leaving 2,796 shares worth $1.4M. The position accounts for 0.42% of the portfolio, ranked #61.

Core Alternative Capital first reported a position in TMO in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.66M in Q3 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Core Alternative Capital held 2,796 shares of Thermo Fisher Scientific worth $1.4M as of Q2 2026.
  • Core Alternative Capital sold 206 Thermo Fisher Scientific shares in Q2 2026, an estimated $98.9K.
  • Thermo Fisher Scientific made up 0.42% of Core Alternative Capital's portfolio in Q2 2026, its #61 holding.
  • Core Alternative Capital first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 20 quarters since.
  • Core Alternative Capital's Thermo Fisher Scientific position peaked at $2.66M in Q3 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.